The Health Research Board (HRB) is the designated Irish Focal Point for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
The EMCDDA is the central reference point for drug information in the European Union. Set up in 1993, and based in Lisbon, its role is to provide factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences. The HRB works closely with the EMCDDA, with other Focal Points, and with national partners to standardise data collection in the EU. By standardising data, valid comparisons can be made about current patterns and emerging trends in drug use in Europe.
The EMCDDA monitors the drugs situation in Europe the responses to drug-related problems, including harm reduction measures. The Centre also works on the development of tools and instruments to increase data comparability and to facilitate the Member States’ and the Commission’s monitoring and evaluation of their respective policies, and with providing a platform for the exchange of latest evidence and best practice in the field.